Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor
-
Published:2023-05-23
Issue:6
Volume:13
Page:540
-
ISSN:2077-0375
-
Container-title:Membranes
-
language:en
-
Short-container-title:Membranes
Author:
Cortese Katia1ORCID, Ponassi Marco2, Profumo Aldo2ORCID, Coronel Vargas Gabriela2ORCID, Iervasi Erika2ORCID, Gagliani Maria Cristina1, Bellese Grazia1, Tavella Sara23, Castagnola Patrizio2ORCID
Affiliation:
1. DIMES, Department of Experimental Medicine, Cellular Electron Microscopy Lab, Università di Genova, Via Antonio de Toni 14, 16132 Genova, Italy 2. IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy 3. DIMES, Department of Experimental Medicine, Cellular Oncology Unit, Università di Genova, Largo Rosanna Benzi 10, 16132 Genova, Italy
Abstract
Trastuzumab (Tz), an antibody targeting ERBB2, has significantly improved the prognosis for breast cancer (BCa) patients with overexpression of the ERBB2 receptor. However, Tz resistance poses a challenge to patient outcomes. Numerous mechanisms have been suggested to contribute to Tz resistance, and this study aimed to uncover shared mechanisms in in vitro models of acquired BCa Tz resistance. Three widely used ERBB2+ BCa cell lines, adapted to grow in Tz, were examined. Despite investigating potential changes in phenotype, proliferation, and ERBB2 membrane expression in these Tz-resistant (Tz-R) cell lines compared to wild-type (wt) cells, no common alterations were discovered. Instead, high-resolution mass spectrometry analysis revealed a shared set of differentially expressed proteins (DEPs) in Tz-R versus wt cells. Bioinformatic analysis demonstrated that all three Tz-R cell models exhibited modulation of proteins associated with lipid metabolism, organophosphate biosynthesis, and macromolecule methylation. Ultrastructural examination corroborated the presence of altered lipid droplets in resistant cells. These findings strongly support the notion that intricate metabolic adaptations, including lipid metabolism, protein phosphorylation, and potentially chromatin remodeling, may contribute to Tz resistance. The detection of 10 common DEPs across all three Tz-resistant cell lines offers promising avenues for future therapeutic interventions, providing potential targets to overcome Tz resistance and potentially improve patient outcomes in ERBB2+ breast cancer.
Funder
Italian Ministry of Health University of Genova research
Subject
Filtration and Separation,Chemical Engineering (miscellaneous),Process Chemistry and Technology
Reference33 articles.
1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/Neu Oncogene;Slamon;Science,1987 2. Studies of the HER-2/Neu Proto-Oncogene in Human Breast and Ovarian Cancer;Slamon;Science,1989 3. ErbB Receptors and Cancer;Wang;Methods Mol. Biol.,2017 4. Braicu, C., Buse, M., Busuioc, C., Drula, R., Gulei, D., Raduly, L., Rusu, A., Irimie, A., Atanasov, A.G., and Slaby, O. (2019). A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers, 11. 5. Akt in Cancer: Mediator and More;Revathidevi;Semin. Cancer Biol.,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|